IRIX (IRIDEX) Current Accrued Expense: $0.69 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IRIX IRIDEX Corp IRIX
56 GF Score
Price $0.82
GF Value $1.70
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is IRIDEX Current Accrued Expense?

IRIDEX IRIX -1.39% 56 Current Accrued Expense is $0.69 Mil as of Mar. 2026. GuruFocus rates IRIX with a GF Score™ of 56/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review.

IRIDEX's Current Accrued Expense for the quarter that ended in Mar. 2026 was $0.69 Mil.

IRIDEX's quarterly Current Accrued Expense increased from Sep. 2025 ($0.59 Mil) to Dec. 2025 ($0.82 Mil) but then declined from Dec. 2025 ($0.82 Mil) to Mar. 2026 ($0.69 Mil).

IRIDEX's annual Current Accrued Expense declined from Dec. 2023 ($2.06 Mil) to Dec. 2024 ($0.77 Mil) but then increased from Dec. 2024 ($0.77 Mil) to Dec. 2025 ($0.82 Mil).

IRIDEX Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for IRIDEX's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IRIDEX Current Accrued Expense Chart

IRIDEX Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 1.55 2.06 0.77 0.82

IRIDEX Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.58 0.59 0.82 0.69
IRIX
56GF Score
IRIDEX Corp IRIX
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IRIDEX Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.69 Mil mean?
IRIDEX (IRIX) has a Current Accrued Expense of $0.69 Mil as of Mar. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on IRIDEX and its competitors.
Is IRIDEX's Current Accrued Expense too high?
IRIDEX's current Current Accrued Expense is $0.69 Mil. Overall, IRIDEX has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's Current Accrued Expense compare to NMTC and CSDX?
IRIDEX's Current Accrued Expense of $0.69 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on IRIDEX and its competitors. IRIDEX's current Current Accrued Expense is $0.69 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $0.82 — trading 51.7% below its estimated fair value. The current Current Accrued Expense is $0.69 Mil. IRIDEX's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For IRIDEX (IRIX), the current Current Accrued Expense is $0.69 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IRIDEX (IRIX) Overvalued in 2026?

Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued. The current stock price of $0.82 is trading 51.7% below its estimated GF Value™ of $1.70. GuruFocus considers IRIDEX to be Possible Value Trap.

Key valuation signals for IRIX:

  • Current Accrued Expense: $0.69 Mil
  • GF Value™: $1.70 vs. price of $0.82 (51.7% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IRIDEX Business Description

Address 1212 Terra Bella Avenue, Mountain View, CA, USA, 94043
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
56GF Score

Get the complete analysis for IRIX

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.82
Price
$1.70
GF Value